Overview
Fred Hutchinson Cancer Center is a distinguished independent, nonprofit organization headquartered in Seattle, Washington. Founded in 1975, the center is acclaimed for its pioneering contributions to cancer treatment and research, with a dual focus on cancer and infectious diseases. Partnering with UW Medicine, Fred Hutch plays a pivotal role in the regional and international cancer treatment landscape. Designated as a comprehensive cancer center by the National Cancer Institute, it is the only such center in the Pacific Northwest, placing it among 41 elite centers in the United States dedicated to cancer research advancements.
Mission and Vision
Fred Hutch dedicates itself to eradicating cancer and related diseases through both preventive and curative approaches. The center embraces a mission rooted in diversity, equity, and inclusion, aspiring to serve humanity through compassionate care and innovative scientific research. It aims to accelerate the development and advancement of biomedical technologies in the quest to eliminate cancer and other critical diseases.
Leadership
President and Director
- Dr. Thomas J. Lynch Jr.: A globally respected oncologist and scientist, Dr. Lynch directs the organization with a focus on innovation in cancer treatment. Holding the Raisbeck Endowed Chair, he has extensive leadership experience from Yale and Bristol Myers Squibb.
Key Executives
- Fred Appelbaum, MD: Executive Vice President, oversees strategic research partnerships and holds the Metcalfe Family/Frederick Appelbaum Endowed Chair.
- Bruce Clurman, MD, PhD: Executive Vice President and Chief Scientific Officer, integrates scientific research with clinical application.
- Nancy Davidson, MD: Executive Vice President of Clinical Affairs and a renowned breast cancer researcher, holding the Raisbeck Endowed Chair for Collaborative Research.
Board of Directors
- Leigh Morgan, Chair: CEO of Imaginal Leadership Strategies and a member of the Council on Foreign Relations, with broad leadership experience at global institutions.
Additional Key Personnel
- Jim Rudd: Associate VP & Chief Technology Officer
- Victoria Quiles: Chief Philanthropy Executive, Donor Engagement
- Rosemarie Keenan: Associate VP, Public Health Sciences
- Julie Schlesinger: Associate VP for Research Administration and Faculty Affairs
- Dan Meenach: Associate VP, Translational Science & Therapeutics Division
- Kenny Lind: Chief Engineer
Research and Achievements
Fred Hutch's research reaches over 60 countries, leading to significant medical breakthroughs. Contributions from three Nobel Prize winners underscore its substantial impact on global health. The organization is celebrated for innovations, notably in bone-marrow transplantation.
Facilities and Operations
The Fred Hutch campus covers over 16 acres in South Lake Union, Seattle. These state-of-the-art facilities promote collaboration and innovation. The organization employs over 6,100 people, uniting scientists, clinicians, and support staff in its mission.
Recent Developments
Recent initiatives at Fred Hutch include:
- Cellular tagging innovations targeting lung tumors.
- Enhancement of patient care efficiency through an expanded nurse navigation program.
- Leading studies examining blood cell mutations in transplant patients.
Fred Hutch has undergone structural changes under Dr. Thomas J. Lynch's leadership, aligning operations with cutting-edge research needs, especially in cell therapy and preclinical research.
Community and Global Impact
Fred Hutch significantly influences the community and the broader medical field, evidenced by a $60.8 million contribution to research breakthroughs. Its strategic ventures and partnerships enhance its global presence by aligning with renowned institutions for collaborative efforts.
Philanthropy and Support
The center encourages public involvement in various fundraising initiatives, recognizing the importance of community support in sustaining research and innovation. Contributions aid groundbreaking research and enable life-saving treatments and trials.
Competitor Profile
Fred Hutch operates in a competitive research landscape with prominent institutions, including:
- City of Hope
- Cleveland Clinic
- Dana-Farber Cancer Institute
- Harvard Clinical Research Institute / Baim Institute
- Moffitt Cancer Center
- Roswell Park Comprehensive Cancer Center
- Fox Chase Cancer Center
Additional competitors are Apex Vascular and Interventional Physicians, San Fernando Valley Cancer Center, Advanced Cancer Treatment Center, and the J. Craig Venter Institute.
Strategic Collaborations
Fred Hutch collaborates strategically with biotechnology and technology firms, philanthropic supporters, research colleagues, and policymakers to propel scientific advances. This collaborative approach fosters a rich environment of innovation and discovery, underscoring the center's role as a leader in cancer research and treatment.
